Obesity or adipokines-which should be targeted for venous thromboembolism prevention?
J Thromb Haemost
.
2023 Feb;21(2):195-197.
doi: 10.1016/j.jtha.2022.11.008.
Author
Setor K Kunutsor
1
Affiliation
1
Diabetes Research Centre, University of Leicester, Leicester General Hospital, Gwendolen Road, Leicester, UK. Electronic address:
[email protected]
.
PMID:
36775413
DOI:
10.1016/j.jtha.2022.11.008
No abstract available
Publication types
Comment
MeSH terms
Adipokines*
Anticoagulants
Humans
Obesity / complications
Venous Thromboembolism* / prevention & control
Substances
Adipokines
Anticoagulants